Viewpoint Molecular Targeting
Viewpoint has developed a patented image-guided therapy for metastatic melanoma that is poised for Phase I clinical trials in humans.
- Stage Product In Development
- Industry Biotechnology
- Location Iowa City, IA, USA
- Currency USD
- Founded October 2008
- Employees 3
- Website viewpointmt.com
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.